Development of the Actinide Decorporation Agent HOPO-101 for Broad Spectrum Heavy Metal Exposure
Award Notice Posted
- Solicitation number
- 75A50124C00062
- Agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Awarded
- to Hopo Therapeutics, Inc.
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 75A50124C00062 Federal contract award
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Place of performance
- Berkeley, Missouri, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
This Award Notice announces the award of a Cost Contract to HOPO THERAPEUTICS, INC. by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response for the development of the Actinide Decorporation Agent HOPO-101 for broad spectrum heavy metal exposure. The contract was awarded on September 30, 2024 for $226,309,811.00 due to the uncertain and research and development nature of the requirements.
Notice text
This contract was awarded as a Cost Contract based on the research and development nature of the contract. Dueto the uncertainties involved in the contract performance related to the requirements, the Government is not able to estimate with sufficient accuracy the level of efforts or costs for the work.
Awarded contract 75A50124C00062 to HOPO THERAPEUTICS, INC. for 226309811.00 on 2024-09-30.
Notice history
5 of 13 notices listed here. See the rest on GovTribe.
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity